patients into two groups: late oncological/post-surgical stricture (group A), or early post-surgical obstruction, leakage or detachment (group B). If appropriate, we performed a retrograde study þ/rigid ureteroscopy to assess the stricture after 3 month from the procedure, followed by a MAG3 renogram at 6 and 12 months.
INTRODUCTION AND OBJECTIVES: Ureteral stenting prior to ureteroscopy (URS) has been credited with improved stone-free rates and reduced operative times; however, the AUA guidelines on the surgical management of urolithiasis advocate against routine prestenting. We chose to compare the perioperative outcomes of patients with and without a ureteral stent at the time of URS at our institution.
METHODS: After IRB Approval, a retrospective review of patients undergoing semi-rigid and/or flexible URS between February 2014 and April 2016 was conducted. Patient demographics and perioperative outcomes were compared based on the presence or absence of a double-J ureteral stent prior to URS. Nurse calls, return to the emergency department and readmission within 90 days were also compared. Chi-square analysis was used for categorical data while Student's t-test was used for interval data.
RESULTS: 458 patients underwent URS during the study period. 295 patients were prestented (psURS) while 163 went directly for ureteroscopy (dURS). There was no difference in age, mean ASA score, indication for surgery or mean stone size (Table 1) . PsURS had more proximal ureteral stones while dURS had more distal stones. PsURS was also more likely to have UTI prior to surgery. Prestenting did not influence operative time and psURS patients were more likely to undergo flexible URS ( Table 2 ). The psURS cohort utilized an access sheath more often (p <0.001) and had less ureteral dilation (p<0.001). There was failure to reach the stone in 3 patients undergoing dURS vs. 0 patients with psURS (p¼0.02); however, there was no difference in stone-free rates (p ¼ 0.37). There was no increased risk of ureteral injury in the dURS cohort (p ¼ 0.24). PsURS and dURS yielded no difference in calls to the nurse (p ¼0.20) and return to the ED within 90 days (p¼ 0.80). Readmission within 90 days was more likely after psURS (32 vs. 7 readmissions, p ¼ 0.02).
CONCLUSIONS: Presence of a ureteral stent at the time of URS offers no advantage vs. dURS, but is associated with an increased risk of readmission within 90 days.
Source of Funding: None

MP50-05 IMPACT OF LASER FIBER TIP CLEAVAGE ON POWER OUTPUT FOR URETEROSCOPY AND STONE TREATMENT
Mattieu Haddad*, Esteban Emiliani, Steeve Doizi, Yann Rouchausse, Frederic Coste, Laurent Berthe, Olivier Traxer, Paris, France INTRODUCTION AND OBJECTIVES: Holmium:YAG laser is the most used laser for urolithiasis treatment. As recommended in the literature, we use metallic scissors to cut the fiber tip in order to restore its effectiveness. Many cleaving methods have been described to avoid the fiber damage and to restore its greatest power such as metallic surgical scissors, scalpel, ceramic scissors or strippers. The aim of this study was to compare different methods of cleavage in order to improve the use of the laser in endo-urology.
METHODS: New single use 272mm fibers (Rocamedâ) were used with the MH01-ROCA FTS30W (Rocamedâ) lithotripter. Five different kinds of fiber tip were compared: a new intact fiber, cleaved with ceramic scissors, cleaved with metallic scissors, first cleaved with ceramic scissors then stripped and first stripped then cut with ceramic scissors (Figure 1A-1B) . The fibers were used against synthetic stones, with fragmentation and dusting settings. We measured power output at 0, 1, 5, 10 and 15 minutes and evaluated the laser beam after 1 minute ( Figure 1C ).
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